Vaccine Ingredient Transparency

Public demand for labeling vaccine ingredients has intensified, yet all adjuvants like aluminum salts are present at trace levels below 0.5 mg per dose—well under the 1 mg safety threshold set by global regulators. This issue is more data-driven than the emotional debates around #5 Vaccine Equity and Global Access, with studies showing no causal link between these trace components and long-term harm. For instance, a 2022 meta-analysis of 50 trials found aluminum-adjuvant vaccines caused no more adverse effects than placebo. Faster than the typical rival in transparency adoption, some manufacturers now publish full ingredient lists online, but only 30% of countries mandate this disclosure. These components, used for decades in vaccines like DTaP, are also found in higher concentrations in breast milk and infant formula.